持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/19 | 4,080 | 4,270 | 4,055 | 4,180 | +275 | +7% | 215,200 |
2020/03/18 | 3,655 | 4,350 | 3,630 | 3,905 | +255 | +7% | 222,500 |
2020/03/17 | 3,200 | 3,700 | 3,180 | 3,650 | +400 | +12.3% | 143,600 |
2020/03/16 | 3,295 | 3,445 | 3,245 | 3,250 | +20 | +0.6% | 109,100 |
2020/03/13 | 3,245 | 3,285 | 3,080 | 3,230 | -225 | -6.5% | 148,400 |
2020/03/12 | 3,565 | 3,590 | 3,425 | 3,455 | -200 | -5.5% | 108,500 |
2020/03/11 | 3,590 | 3,715 | 3,590 | 3,655 | +30 | +0.8% | 97,900 |
2020/03/10 | 3,615 | 3,660 | 3,475 | 3,625 | -20 | -0.5% | 110,700 |
2020/03/09 | 3,695 | 3,755 | 3,605 | 3,645 | -140 | -3.7% | 64,000 |
2020/03/06 | 3,820 | 3,835 | 3,780 | 3,785 | -90 | -2.3% | 57,600 |
2020/03/05 | 3,850 | 3,905 | 3,825 | 3,875 | +115 | +3.1% | 54,100 |
2020/03/04 | 3,750 | 3,835 | 3,705 | 3,760 | -55 | -1.4% | 67,200 |
2020/03/03 | 3,940 | 3,955 | 3,815 | 3,815 | -55 | -1.4% | 71,000 |
2020/03/02 | 3,710 | 3,885 | 3,710 | 3,870 | +75 | +2% | 78,300 |
2020/02/28 | 3,825 | 3,865 | 3,785 | 3,795 | -145 | -3.7% | 74,500 |
2020/02/27 | 3,980 | 3,980 | 3,920 | 3,940 | -50 | -1.3% | 68,200 |
2020/02/26 | 4,030 | 4,030 | 3,950 | 3,990 | -75 | -1.8% | 76,700 |
2020/02/25 | 4,110 | 4,135 | 4,065 | 4,065 | -210 | -4.9% | 76,000 |
2020/02/21 | 4,240 | 4,305 | 4,240 | 4,275 | +15 | +0.4% | 35,200 |
2020/02/20 | 4,260 | 4,320 | 4,260 | 4,260 | -10 | -0.2% | 38,900 |
2020/02/19 | 4,275 | 4,340 | 4,270 | 4,270 | +55 | +1.3% | 43,200 |
2020/02/18 | 4,245 | 4,260 | 4,200 | 4,215 | -75 | -1.7% | 34,700 |
2020/02/17 | 4,290 | 4,310 | 4,255 | 4,290 | -15 | -0.3% | 32,700 |
2020/02/14 | 4,235 | 4,305 | 4,225 | 4,305 | +40 | +0.9% | 44,600 |
2020/02/13 | 4,235 | 4,285 | 4,185 | 4,265 | +15 | +0.4% | 55,500 |
2020/02/12 | 4,350 | 4,350 | 4,250 | 4,250 | -110 | -2.5% | 49,300 |
2020/02/10 | 4,370 | 4,450 | 4,350 | 4,360 | -10 | -0.2% | 64,600 |
2020/02/07 | 4,340 | 4,395 | 4,300 | 4,370 | +100 | +2.3% | 66,100 |
2020/02/06 | 4,260 | 4,310 | 4,255 | 4,270 | +60 | +1.4% | 56,400 |
2020/02/05 | 4,220 | 4,245 | 4,190 | 4,210 | +25 | +0.6% | 42,000 |
2020/02/04 | 4,130 | 4,190 | 4,115 | 4,185 | +30 | +0.7% | 28,400 |
2020/02/03 | 4,100 | 4,205 | 4,100 | 4,155 | +30 | +0.7% | 58,500 |
2020/01/31 | 4,135 | 4,175 | 4,125 | 4,125 | -5 | -0.1% | 33,100 |
2020/01/30 | 4,195 | 4,195 | 4,120 | 4,130 | -85 | -2% | 47,500 |
2020/01/29 | 4,210 | 4,220 | 4,180 | 4,215 | +15 | +0.4% | 33,700 |
2020/01/28 | 4,175 | 4,225 | 4,145 | 4,200 | -20 | -0.5% | 56,200 |
2020/01/27 | 4,250 | 4,250 | 4,205 | 4,220 | -100 | -2.3% | 39,900 |
2020/01/24 | 4,355 | 4,355 | 4,315 | 4,320 | -35 | -0.8% | 37,300 |
2020/01/23 | 4,390 | 4,390 | 4,320 | 4,355 | -65 | -1.5% | 47,000 |
2020/01/22 | 4,445 | 4,450 | 4,395 | 4,420 | +5 | +0.1% | 38,200 |
2020/01/21 | 4,395 | 4,430 | 4,395 | 4,415 | -25 | -0.6% | 30,600 |
2020/01/20 | 4,400 | 4,445 | 4,400 | 4,440 | +25 | +0.6% | 21,400 |
2020/01/17 | 4,400 | 4,435 | 4,380 | 4,415 | +50 | +1.1% | 42,100 |
2020/01/16 | 4,370 | 4,390 | 4,320 | 4,365 | ±0 | ±0% | 48,600 |
2020/01/15 | 4,410 | 4,430 | 4,345 | 4,365 | -10 | -0.2% | 42,900 |
2020/01/14 | 4,400 | 4,400 | 4,310 | 4,375 | -70 | -1.6% | 68,100 |
2020/01/10 | 4,435 | 4,480 | 4,425 | 4,445 | +40 | +0.9% | 35,300 |
2020/01/09 | 4,415 | 4,435 | 4,335 | 4,405 | +55 | +1.3% | 33,000 |
2020/01/08 | 4,315 | 4,395 | 4,275 | 4,350 | -35 | -0.8% | 56,500 |
2020/01/07 | 4,290 | 4,405 | 4,290 | 4,385 | +100 | +2.3% | 39,800 |
1301~
1350
件表示中 / 3740件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 295,400円 | +5.1% | -7.0% | 2.71% | 19.39倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 212,700円 | - | - | 0.00% | - | 98.51倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ゼリア新薬 | 206,700円 | +3.1% | -6.5% | 2.32% | 9.59倍 | 1.02倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 150,500円 | -2.4% | -52.3% | 3.79% | 18.01倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 86,800円 | +20.3% | - | 0.00% | 153.90倍 | 1.14倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム